Short-term results of treatment of staphylococcal periprosthetic hip joint infection with combined antibiotics and bacteriophages treatment
Open Access
- 17 October 2021
- journal article
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 6 (4) , 50-63
Abstract
Infectious complications after primary implantation of the hip joint are 0.5–3 %, and in the case of re-endoprosthetics, the risk of periprosthetic infection can reach 30 %. Also, we should not forget about the high percentage (16–20 %) of recurrence of periprosthetic infection of the hip joint, which leads to an unsatisfactory result of treatment up to amputation of a limb or even death of the patient. The reasons for the recurrence of the infectious process can be antibiotic resistance and antibiotic tolerance of microorganisms, as well as the ability of microorganisms to form biofilms on implants. In this regard, there is a constant need to search for alternative means of antimicrobial therapy, as well as to select the optimal ways of their delivery and deposition, which is of practical importance when performing surgical interventions in traumatology and orthopedics to protect the implantable structure from possible infection of the surgical site. One of the methods currently available to combat bacterial infections acquired antibiotic resistance and antibiotic tolerance is the use of natural viruses that infect bacterial bacteriophages. The above suggests a more effective suppression of periprosthetic infection, including persisters that deviate from antibiotics. It is, as a rule, associated with biofilms if used in conjunction with antibiotics and phages, when the use of bacteriophages predetermines the effectiveness of treatment. With the use of sensitive bacteriophages in the treatment of periprosthetic infections, a significant (p = 0.030) reduction in the rate of recurrence of infection (from 31 to 4.5 %) was observed. The use of lytic bacteriophages in traumatology and orthopedics is of great interest for phagotherapy of infections caused by antibiotic-resistant and biofilm-forming strains of bacteria. A clinical study using a single-stage surgical revision with simultaneous application of antibiotics and phages in the treatment of deep periprosthesis infection of the hip joint endoprosthesis, followed by 12 months follow-up for periprosthetic infection recurrence, demonstrated the effectiveness of the use of combined antibiotic and bacteriophages treatment.Keywords
This publication has 42 references indexed in Scilit:
- One-Stage Exchange Arthroplasty for Chronic Periprosthetic Hip Infection: Results of a Large Prospective Cohort StudyJournal of Bone and Joint Surgery, 2014
- Randomized Controlled Trial of the Safety and Efficacy of Daptomycin versus Standard-of-Care Therapy for Management of Patients with Osteomyelitis Associated with Prosthetic Devices Undergoing Two-Stage Revision ArthroplastyAntimicrobial Agents and Chemotherapy, 2012
- Two-stage Total Hip Arthroplasty: How Often Does It Control Methicillin-resistant Infection?Clinical Orthopaedics and Related Research, 2011
- Persister CellsAnnual Review of Microbiology, 2010
- Recombinant bacteriophage lysins as antibacterialsBioengineered Bugs, 2010
- The importance of being persistent: heterogeneity of bacterial populations under antibiotic stressFEMS Microbiology Reviews, 2009
- Periprosthetic Infection Due to Resistant Staphylococci: Serious Problems on the HorizonClinical Orthopaedics and Related Research, 2009
- Persister cells, dormancy and infectious diseaseNature Reviews Microbiology, 2006
- Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymeraseMicrobiology, 1998
- TREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATIONThe Lancet, 1944